Effects of GLP-1 Analogs on Cardiovascular Health

Dr. Richard Shannon, University of Pennsylvania, during the VBWG meeting at AHA in LA, recognizes that Diabetes is a CVD equivalent and focuses on the importance that incretins can play in improving hemodynamics and outcomes in Heart Failure.